Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 6, 2021; 9(28): 8349-8357
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8349
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8349
Group | Age | Course of disease | Number of pregnancies | Pregnancy times (times) | BMI (kg/m2) |
Fenmatong group | 34.02 ± 3.89 | 3.45 ± 0.61 | 2.05 ± 0.36 | 1.32 ± 0.28 | 23.17 ± 1.24 |
Observation group | 33.74 ± 4.29 | 3.38 ± 0.57 | 1.98 ± 0.45 | 1.37 ± 0.26 | 23.06 ± 1.48 |
t | 0.390 | 0.676 | 0.979 | 1.055 | 0.459 |
P value | 0.697 | 0.500 | 0.329 | 0.293 | 0.647 |
- Citation: Lin XM, Chen M, Wang QL, Ye XM, Chen HF. Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function. World J Clin Cases 2021; 9(28): 8349-8357
- URL: https://www.wjgnet.com/2307-8960/full/v9/i28/8349.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i28.8349